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Abstract 
The main purpose of the study was to investigate the fasting of blood sugar (FBS) levels fluctuation over time 
and the effect of some plausible factors on this change for Diabetic’s patients on treatment and Balanced Diet 
(BD). To this end, we analyzed the FBS levels in both gender and age groups by using profile analysis to study 
the patterns of their changes. In this study, we used Retrospective data from Rwanda Diabetics Association 
(RDA) containing patient’s FBS level, gender and age data, regularly obtained every three months. The 
MANOVA test of parallelism on treatment and BD showed at 5% significance level that the profiles in gender 
and age groups were parallel. The distance between profiles was not significant, but not flat. The analysis 
revealed that although the treatment remained effective, the trends of FBS levels over time were quadratic in 
treatments and BD. Furthermore, the rates of FBS change on treatment and BD were a function of time. These 
models and rates indicated that only treatment have the positive impact on FBS level while the BD has no effect. 
Keywords: FBS level, Balanced Diet, trend model  
 
1. Introduction 
Diabetes mellitus is one of the most dangerous disease characterized by the lack of ability to regulate blood 
sugar levels of the body, resulting in chronically increased blood sugar levels, or hyperglycemia. Diabetes has 
two types: Type 1 and Type 2, People who have Type 1 diabetes do not produce insulin which converts blood  
sugar and starches into energy and type 1 diabetes used to be called juvenile onset diabetes because it is usually 
diagnosed in adolescence. Type 2 diabetes mellitus, the most common form of diabetes, results from an 
imbalance between insulin sensitivity and insulin secretion and comprises 90% of people with diabetes around 
the world while type 1 comprises 10% (Wang, Sun et al. 2014). In the past years, the global rise in non-
communicable diseases (NCDs) represented one of the major health and socioeconomic threats in the 21st 
century. Among NCDs, diabetes mellitus remains a tragically diseases because of its prevalence and the related 
complications worldwide(Garg, Bantle et al. 1994). In sub-Saharan Africa, while communicable diseases such as 
HIV/AIDS, malaria, and tuberculosis have continued to provoke great threats to the public health system, it is 
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now shown that   NCDs such as diabetes are undoubtedly adding to the multiple burdens for people in this 
region(Liu, Fu et al. 2010). In the research conducted in 2010 by Shaw about diabetes and its complications  has 
revealed that the prevalence of diabetes among adults between 20 and 79 ages old was found to be 6.4%, 
affecting 285 million adults all over the world (Shaw, Sicree et al. 2010). Likewise the research conducted in 
Kigali University Teaching Hospital (CHUK) in 2012 has shown that out of 294 patients ( 104 males and 190 
females)  constituted the study population, 70 (24%) were diagnosed with type 1 while 224 (76%) had  type 2 
diabetes(Rudasingwa, Amendezo et al. 2012). On the other hand, the research carried out at Ketu-South 
Municipality in Ghana about the prevalence of type 2 diabetes showed that the FBS level for 80 diabetic patients 
on drug was containing 23.75% suggesting that aging increases the chances of having diabetes of  type 2 and 
females (67.5%) were almost twice as the males (32.5%). The high number of females was compared to males 
and due to the higher physical activity-related consuming the energy in males compared to female subjects, so 
decrease the  rate of males living with type 2 diabetes. The low level of diabetes-related health expenditures has 
prevented a very small proportion (0.06%) of diabetes-related deaths. Increased funding for cost-effective 
diabetes prevention and treatment is a need (Adampah, Luguterah et al.). Similar conclusions were made 
by(Scavini, Stidley et al. 2003) who found that the prevalence of diabetes was 57% higher among females than 
male members of the population. 
In 2011, there were approximately 180 million people worldwide with diabetes and its complications (Tuei, 
Maiyoh et al. 2010). In 2000, WHO showed that 7020000 of people were lived with diabetes in Africa(Wild, 
Roglic et al. 2004). Rwanda had 30000 lived with diabetes at that time and was subjected to a yearly increase.  
To decrease its rate,  regular physical activity was strongly recommended for people with diabetes to  improve 
their fasting blood sugar level control, insulin sensitivity, prevention and reduction of morbidities and 
complications (Kabanda and Phillips 2011).Progressively, Rwanda is becoming  one of the fastest developing 
countries in Africa. However, the management of economic development for local people is not yet 
standardized(Giddens 2018). This fact leads to the increment of diabetics due to the low economic development 
which limits the affordability of treatment and accessibility of health facilities(Phelos 2017). Therefore, some 
diabetics have been assigned to treatments and others to BD  according to their fasting blood sugar level. 
Furthermore, diabetics are likely to occur in many populations and at an early stage. By reflecting to that issues, 
this research comprises techniques to analyze the fasting blood sugar level for diabetic’s patients by applying 
profile analysis.   
1.1. Profile Analysis 
Generally, the profile analysis is a multivariate tool for analyzing the profile of variables across groups especially 
for repeated measures or mixed ANOVA, and also is a multivariate approach which uses separate correlated 
response variables. It is normally used in different kind of data. Mostly for these two different types that are 
measured over time: time series, which takes many measurements on a small set of individuals, and longitudinal 
data, which takes a small number of measurements on a large number of individuals. It deals with three tests: 
Test of Parallelism, Test of Levels (Separation) and Test of Flatness. The main test is to know if the profiles of 
group levels are parallel, are at the same level and are flat. Profile analysis asks three basic questions about the 
data plots:  
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 Are the groups parallel between time points? 
 Are the groups at equal levels across time points? 
 Do the profiles are flatness across time points?  
If the answer to any of these hypothesized questing is no i.e. that specific null hypothesis is rejected, then there is 
a significant effect. The type of effect depends on which of these null hypotheses is rejected.  
This hypothesis can be written mathematically as follow:  
H0: Are the profiles similar in the sense of being parallel? 
H1: , − , = , − , for j= 1, 2, 3…p where p is the set of measurements and , is the means of 
each group. 
 H0: Are they at the same level? 
H2: 
	
,
	
;⋯	
,

=
	,
	,⋯	,

  
The same level means within groups are on the same line. 
H0: Are they flat? 
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The flatness means that the profiles are horizontal. 
The analysis of these hypotheses is based on the Hotelling’s test (T2). The Hotelling test (T2) is used to test 
whether the population means of the K+1 random vectors and response variable are equal. The rejection of the 
null hypothesis is when T2 > χ2 (α). This test is exactly chi-square distributed with p degree of freedom. For 
small samples, the chi-square approximation to T2 does not take into account variation due to estimating the 
samples variance-covariance matrix S (Morrison 2005).  
Therefore, better result be obtained from the transformation of the Hotelling’s test (T2) statistic to F statistic as 
follow:  = 

∗  and was compared with P-value generated by the software where n-1 is a degree of 
freedom, and p indicating measurement recorded. 
2. Methods 
The design of this study is repeated measures for longitudinal second data that have been provided by RDA in 
the group of Gender (male and female) and Age (under forty and above forty years old) in 2015.The process of 
obtaining the data was authorized by RDA and UR University, College of Science and Technology (SCT). In 
this research 152 individuals were enough to analyze the change of FBS level of diabetic patients. 76 individuals 
assigned to treatment and 76 individuals for BD by random samples. SSPS software has been used to analyze the 
data and manually calculation of some parameters in the model. The MANOVA was used to show the effect of 
treatment and BD on the FBS level in the interval of time of t= 0, 3, 6 months and the profile plots and tests also 
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have been used to show the pattern effect of both treatment and BD. This research was based on this hypothesis 
of interest:  
H0: There is no significance effect of treatment or BD on FBS level in groups of patients. 
H1: There is an effect of treatment and BD on FBS level in a group of patients. 
The application of profile analysis enclosed all analysis and interpretation of data and answer the above 
hypothesis. 
3. Results  
This following analysis was based by applying the transformation of the Hotelling’s test (T2) statistic into F- 
statistic as follow:   = 

∗   and compared with P-value generated by the software, and F- value 
generated by the software did not take into account only T2 and P-value were used in this analysis. 
3.1. Descriptive statistics 
The females and males were equal and the mean change in FBS level for males before taking treatment for 
diabetics was 281.11 mg/dl whiles that of the females was 239.11 mg/dl. After taking first and second treatments 
for, FBS level was 77.76 mg/dl and 81.39 mg/dl respectively. While for the diabetics patients under forty years 
old before taking first treatment FBS level were 263.54 mg/dl and for patients above thirty nine years old were 
258.52 mg/dl. After taking the second and third treatments, the mean changed to 79.58 mg/dl. The standard 
deviation decline at high rate that implies high deviation of FBS level with presence of treatment. 
The females and males were not equal and the mean of FBS level for males and females before guided to take 
BD (balanced diet) for diabetics was 273.32 mg/dl mg/dl and 223.39mg/dl respectively. After taking second and 
third BD, the means of FBS level were 248.03 mg/dl and 
271.51 mg/dl respectively. The mean of FBS level for under forty years old and above after guided to take first 
and second BD for diabetics was 260.44 mg/dl and 276.94 mg/dl respectively. The standard deviation are too big 
that implies slow change of FBS level. Throughout the BD, the means of FBS level of patients does not decrease 
at a significance rate which shows that BD cannot affect FBS level. The standard deviation is too big implies 
slow deviation of FBS level (Table 1). 
3.2. Profile plots of FBS in Age and Gender on treatment 
The pattern of change in FBS level over the period of observation for group of age were showed that both below 
40 years old and above 40 initially Were at high level sharply but group 1 was above of group 2 at t1, both 
declined at the same rate until t2 and after that, both seem to be also changing in almost the same pattern and met 
on t3 (Figure 1) and then the profiles are seemed parallel and flatness. In gender, profiles showed that both sexes 
initially Were at high level sharply but males were above of females at t1, both declined but males declined at 
high rate than females until t2 and after that, both seemed to be changing in almost the same pattern but with the 
males almost greater than females up to t3 and showed that the profiles are parallel means the distance between 
profiles is not significance but not flat (Figure 2). 
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3.3. Profile plot of FBS in Age and Gender on BD 
The pattern of change in FBS level over the period of observation for age group was shown that both initially 
decreased sharply in the different rate from t1 up to t2 but group 1 decrease at a high rate than group 2. Group 1 
was at the highest level than group 2 at t1, and then both seem to be increasing in almost the same pattern up to t3. 
So the profiles seemed parallel and flatness (Figure 3). For gender, the profiles showed that initially, a group of 
males decreased while a group of female increased sharply in almost the same rate but in opposite directions. 
Males were at the highest level than females at t1, and that of the females increased at a high rate than males until 
t2 and after that, both seemed to be changing in almost the same pattern up to t3 (Figure 4). 
3.4. Test for parallelism, flat and at the same level on treatment 
The hotelling’s test for parallelism in gender groups is T2 = 0.025. F-test was calculated and is equal to F statistic: 
F (3, 72) = 0.0081. The hypothesis H0 is failed to be rejected at 5% significance level since P −value is greater 
than F (3, 72) = 0.416 The hoteling’s test for parallelism in age groups was T2 = 0.002. F-test was calculated and 
is equal to F statistic: F (3, 72) = 0.00064. The hypothesis H0: the vectors are parallel for two groups (under 40 
years and 40 and above years), did not rejected at 5% significance level since P−value is greater than F (3, 72)= 
0.918. Generally, these profiles either in gender and age groups are parallel since the null hypotheses did not 
rejected. So there is no interaction effect of time and groups (Table 2). 
The hotelling’s test for flatness in gender groups is T2 = 1.237.  F statistic: F (3, 72) = 0.401. The hypothesis H0 
is rejected at the 5% significance level since P −value is less than F (3, 72) = 0.00. The hotelling’s test for 
flatness in age groups was T2 = 1.074. F-test was calculated and is equal to F statistic: F (3, 72) = 0.348. The 
hypothesis H0: the vectors are flatness for two groups (under 40 years and 40 and above years), is rejected at 5% 
significance level since P −value is less than F(3, 72) = 0.00. Generally, all null hypotheses are rejected that 
implies that the profiles are not flat. So they are not horizontal (Table 3). 
According to the results in Table 4, Hotelling test for the same level, the null hypotheses is failed to be rejected 
since P −value is greater than significance level = 0.05. So all profiles are on the same line. 
3.5. Test for parallelism, flat and at the same level on BD 
The hotelling’s test for parallelism in gender groups is T2 =0.034. F-test was calculated and is equal to F statistic: 
F (3, 72) = 0.011. The hypothesis H0 is failed to be rejected at the 5% significance level since P −value is greater 
than F (3, 72) = 0.4301. For age groups was T2 = 0.014. F-test was calculated and is equal to F statistic: F (3, 72) 
= 0.0045. The hypothesis H0: the vectors are parallel for two groups (under 40 years and 40 and above years), 
did not rejected at 5% significance level since P−value is greater than F (3, 72) = 0.611. Generally, these profiles 
either in gender and age groups are parallel since the null hypotheses did not rejected. So there is no interaction 
effect of time and groups (Table 5). 
The hoteling’s test for flatness in gender groups is T2 = 0.293. F-test was calculated and is equal to F statistic: F 
(3, 72) = 0.095. The hypothesis H0 is rejected at the 5% significance level since P −value is less than F (3, 72) = 
0.00. For in age groups was T2 = 0.293. F-test was calculated and is equal to F statistic: 0.095.The hypothesis H0: 
the vectors are flatness for two groups (under 40 years and 40 and above years), is rejected at 5% significance 
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level since P −value is less than F(3,72)= 0.00. Generally, all null hypotheses are rejected implies that the 
profiles are not flat. So they are not horizontal (Table 6). 
According to the results in table 7, the null hypotheses are failed to be rejected since P −value is greater than 
significance level = 0.05. So all profiles are on the same line. 
Interpretation: According to the MANOVA test for the parallelism, all profiles plot in gender and age are 
parallel on treatment and BD. The flatness failed and the profiles are on the same line, implies that the distance 
between profiles is not significance. 
3.6. Fitted mathematical models 
The linear model and quadratic model are significance to describe the change of FBS level with respect to the 
time interval in which the patients had been taking the treatment and requested to take BD but according to the 
coefficient of determination (R square), the quadratic model was appropriate. The averaged quadratic model has 
been tested by heteroscedasticity residuals test and showed that R2 = 0.889 on treatment and R2 = 0.711 on BD. 
The fitted model that describing the change in FBS level is shown as follow: The analysis revealed that although 
the treatment remained effective, the trend of FBS level over time was quadratic, indicating that initially the FBS 
level usually increases with time and then also increases with time. The quadratic profile trend obtained was FBS 
(t) = 0.44t2 +3.173t. And also the rate of change of FBS on treatment was ( )( ) 173.388.0 += t
dt
tFBSd
which 
increased over time. The positive sign of the estimate coefficients indicates the positive effect of treatment of 
FBS level of the patients in the time interval. While for BD, the profile trend obtained was FBS (t) = − 0.688t2 
−11.05t that showed the FBS declined over time and indicating no effect of BD on FBS, and the rate of change 
of FBS on BD was ( )( ) 05.11377.1 −−= t
dt
tFBSd
, which declined over time. The negative sign of this 
estimated parameter indicates the less impact of the BD on the FBS level of patients. Therefore these models and 
rates indicated that only treatment has the positive impact on diabetic’s patients (Table 8). The ARCH-LM 
indicated that the residuals were free from conditional heteroscedasticity (p-value = 0.6051) for BD and (p-
value= 0.7093) for treatments. Hence the diagnostic test revealed that the models are adequate for prediction of 
FBS level. The coefficients of determination (R2 marked with start (*)) in table 8 on treatment and BD also show 
that the parameters estimate are fit the models. 
4. Discussion  
The similar initial increase and then decline in the pattern of change of FBS levels over time for both sexes is an 
automatic indication that the treatment and management plans adopted to bring the situation under control were 
actually addressing the condition irrespective of gender even though performance is better in males than females, 
the same for BD effect on the FBS level. According to descriptive statistics, the females and males were equal 
and the mean change in FBS level after taking first and second treatments for, FBS level was 77.76 mg/dl and 
81.39 mg/dl respectively. While age group after taking the second and third treatments, the mean changed to 
79.58 mg/d. In gender group after taking second and third BD, the means of FBS level were 248.03 mg/dl and 
271.51 mg/dl respectively. While the mean of FBS level for under forty years old and above after guided to take 
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first and second BD for diabetics was 260.44 mg/dl and 276.94 mg/dl respectively. The standard deviation for 
treatment decrease at higher rate while in BD standard deviation decrease at low rate (Table 1). The Hotelling’s 
test of parallelism, equality, and flatness, showed that the pattern for male and female patients is not only the 
same but also almost equal with the average of FBS level changing slowly over time, while gender did not affect 
the change in FBS level, time did and that there is no time and groups interaction. The multivariate test showed 
the greatest significance effect of treatment on the FBS level compared to the effect of BD (Fig 1, 2, 3, and 5). 
The profiling of the FBS level pattern of the different groups is also expressed and all the groups follow almost 
the same trend with respect to time on treatment and also follow the same pattern for BD that shows the BD has 
small effect on the FBS level (Table 8). The ARCH-LM Test for residuals of the quadratic models  confirmed 
that these models are significantly reliable for estimating the FBS level of the patient’s on treatment and on BD 
and this was different with the trend obtained by (Adampah, Luguterah et al.), may be was due to the length of 
the study period was different.  
5. Conclusion 
The mean change of FBS level of diabetics was at higher rate after taking treatment in gender and age group. 
While for those who take BD, the mean of FBS level slightly decrease with low rate and show that BD does not 
have impact on FBS level compared to treatment and confirmed by the standard deviation movements. The 
MANOVA test of parallelism showed that gender was parallel because there was not significant difference in the 
pattern of change of the FBS level. Age groups did not significantly differ at the 5% significance level and hence 
their profiles were tested for parallelism and flatness. The parallelism tests revealed that the profiles were parallel 
and equal but deviated from flatness for treatment but not equal and flat for BD. The model fitted of FBS level 
on the treatment indicated that treatment has positive effect and also indicted by rate of change of FBS level. 
While the fitted model on BD and rate of change indicted the negative effect. It is therefore indicated in the study 
that the treatments are improving the condition of living with diabetes for patients but BD has less contribution 
and indicated that the null hypothesis of the study has been rejected. From this rejection, we can say that 
diabetic’s patients should take treatment rather than BD, for better more they can take both. This research did not 
cover all related angles due to different conditions. So I encourage other researchers to go beyond this 
application of profile analysis and use it in different areas. 
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 Tables 
Table 5: Descriptive Statistics 
Descriptive statistics 
treatment Groups Mean Standard deviation 
T1 Age 1 263.54 74.031 
2 258.52 210.801 
T2 1 94.15 18.376 
2 91.54 16.190 
T3 1 80.46 12.29 
2 19.58 10.902 
T1 Gender/male 281.11 242.975 
female 239.11 68.748 
T2 male 93.11 17.921 
female 92.00 17.061 
T3 male 77.76 11.042 
female 81.39 11.396 
BD1 Age 1 244.84 66.373 
2 250.08 69.835 
BD2 1 241.36 62.474 
2 251.94 56.491 
BD3 1 260.44 74.034 
2 276.94 69.776 
BD1 Gender/male 273.32 66.588 
female 223.39 61.211 
BD2 male 263.61 61.016 
female 262.45 51.788 
BD3 male 292.97 65.865 
female 250.05 70.526 
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Table 2: MANOVA test using the Hotelling test for parallel on treatment 
 
 
 
  
Table 3: MANOVA test using the Hotelling test for flat on treatment 
Group T2-value F P-value  
Age 1.074 39.818 0.00 
Gender 1.237 45.140 0.00 
 
Table 4: MANOVA test using between-subjects effects on treatment test using 
Group M.S F P- value > F 
Age 466.002 0.043 0.837 
Gender 23428.318 1.06 0.285 
Error 1542029.146   
Table 5: MANOVA test using the Hotelling test for parallel on BD 
 
 
 
Table 6: MANOVA test using the Hotelling test for flat on BD 
Group T2-Value F P- value  
Age 0.293 10.401 0.00 
Gender 0.293 10.401 0.00 
 
Table 7: MANOVA test using between-subjects effects on BD 
Group M.S F P- value > F 
Age 6150.453 0.548 0.461 
Gender 1041.99 1.049 0.351 
Error 1987.537   
 
Effect T2-value F p-value >F 
Age 0.002 0.086 0.918 
Gender 0.025 0.899 0.416 
Effect T2-Value F P-value > F 
Age 0.014 0.519 0.611 
Gender 0.034 1.223 0.4301 
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Table 8: Average Models 
Effect EQUATION R-square F Df1 Df2 P- value B1 B2 
treatment Linear 0.691 66.690 1 74 0.00 0.88  
Quadratic 0.889* 52.443 1 74 0.00 3.173 0.44 
BD linear 0.341 18.981 1 74 0.00 -0.93  
quadratic 0.711* 8.112 1 74 0.006 -11.05 -0.688 
 
 
Figures 
Figure 1. Profile plot of FBS level by Age groups on treatment 
 
Figure 2. Profile plot of FBS by Gender on treatment 
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Figure 3. Profile plot of FBS by Age on BD 
 
 
Figure 4. Profile plot of FBS by Gender on BD 
 
 
